SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-005158
Filing Date
2019-02-28
Accepted
2019-02-28 06:50:26
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_EARNINGS RELEASE_12/31/2018 reta-8k_20190228.htm 8-K 29103
2 EX-99.1 PR reta-ex991_6.htm EX-99.1 373535
3 GRAPHIC g3nos0b2n5bd000001.jpg GRAPHIC 6766
  Complete submission text file 0001564590-19-005158.txt   413213
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 19640342
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences